Jazz Pharmaceuticals ($JAZZ) Insider Trading & Smart Money Activity
Jazz Pharmaceuticals plc ($JAZZ) has 3 insider trades, 4 13F position changes and 5 analyst ratings on file. In the last 12 months on the open market, no insider bought and 3 insiders sold ($2.12M), net -$2.12M.
- Insider buyers (12 mo)
- 0
- Insider sellers (12 mo)
- 3
- Net insider $ (12 mo)
- -$2.12M
- Congress trades (12 mo)
- 0
- 13F moves on file
- 4
- Analyst ratings on file
- 5
JAZZ insider buying and selling by quarter
| Quarter | Insider buys | Insider sales | Congress buys / sales | 13F added / cut |
|---|---|---|---|---|
| Q1 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q2 2026 | 0 | 1 · $266.75K | 0 / 0 | 2 / 2 |
| Q3 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q4 2026 | 0 | 2 · $1.85M | 0 / 0 | 0 / 0 |
Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.
All JAZZ insider, congress, 13F and analyst activity
| Date | Source | Who | Action | Shares | Value / amount | ΔOwn | 1W | 1M | 6M | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Analyst | RBC Capital | Reiterates to Outperform | PT $296 | -3.6% | — | ||||||
| Analyst | Truist Securities | Reiterates to Buy | PT $286 | -9.3% | — | ||||||
| Insider | Gala Renee DPresident & CEO | Sell (Open-market sale) 10b5-1 | 2K sh | $472.80K | -9.1% | — | |||||
| Insider | Cozadd Bruce CDirector | Sell (Open-market sale) 10b5-1 | 6K sh | $1.38M | -4.5% | — | |||||
| Analyst | Citigroup | Reiterates to Buy | PT $325 | -0.1% | — | ||||||
| Insider | Smith Mark Douglas | Sell (Open-market sale) 10b5-1 | 1.16K sh | $266.75K | -2.0% | +3.8% | — | ||||
| Analyst | B of A Securities | Reiterates to buy | PT $307 | -1.2% | +6.2% | Read | |||||
| Analyst | B of A Securities | Reiterates to buy | PT $307 | -1.2% | +6.2% | Read | |||||
| 13F | Holocene Advisors | Added | +144.17K sh | $176.85M | +4.8% | +0.8% | — | ||||
| 13F | Holocene Advisors | Added | +144.17K sh | $169.21M | +4.8% | +0.8% | — | ||||
| 13F | Lsv Asset Management | Reduced | -69.12K sh | $575.16M | +2.7% | +2.7% | — | ||||
| 13F | Lsv Asset Management | Reduced | -69.12K sh | $550.31M | +2.7% | +2.7% | — |
1W / 1M / 6M = how JAZZ moved from the trade or filing date.
Insider trading in JAZZ: who is buying and selling
| Insider | Role | Trades | Open-market net | Shares held | Last trade |
|---|---|---|---|---|---|
| Gala Renee D | President & CEO | 1 | -$472.80K | Oct 6, 2026 | |
| Cozadd Bruce C | Director | 1 | -$1.38M | Oct 1, 2026 | |
| Smith Mark Douglas | 1 | -$266.75K | Jun 15, 2026 |
Institutions moving JAZZ (13F)
Analyst ratings on JAZZ
Frequently asked questions
Are JAZZ insiders buying or selling?
Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 3 insiders made 3 open-market sales worth $2.12M, a net -$2.12M.
What is the latest insider trade in JAZZ?
Gala Renee D, President & CEO filed a sell (open-market sale) of 2K sh worth $472.80K on Oct 6, 2026.
Which institutions changed their JAZZ positions?
Recent 13F filers moving the stock include Holocene Advisors and Lsv Asset Management.
Other biotechnology stocks
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.